eed for Vitamin E supplementation in HIV-infected Childre
Not Applicable
- Conditions
- Health Condition 1: B20- Human immunodeficiency virus [HIV]disease
- Registration Number
- CTRI/2022/12/047960
- Lead Sponsor
- niversity college of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
We will include children aged 18 months to 15 years, consisting of 3 groups: Group 1: CLHIV on ART >= 2 years; Group 2: Treatmentâ??naïve CLHIV; Group 3: Healthy age-matched controls.
Exclusion Criteria
Children who are critically ill, had a recent change (within 3 months) in ART regimen, virological failure, receiving multivitamin supplements within preceding 3 months, with serious bacterial infections (SBIs) / opportunistic infections (OIs), with chronic diseases like tuberculosis, chronic liver disorders or renal insufficiency, with hepatitis B or C co-infection, and receiving steroids >=1month duration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum TAC <br/ ><br>Timepoint: Baseline and after 3 months <br/ ><br>
- Secondary Outcome Measures
Name Time Method Serum alpha tocopherol levels, Correlation of serum tocopherol levels and TAC with viral load, CD4 count, CBC with RBC indices and duration of ARTTimepoint: Baseline and after 3 months